Tissue Genesis offers best-in-class, enzyme-derived cell therapy processing solutions using high-performance, point-of-care technology that efficiently extracts adult stem cells from autologous adipose (fat) tissue in a fully-enclosed and automated process.
The Tissue Genesis system pairs the Icellator® with the Icellator® Cartridge Kit: the Cartridge Kit is a single-use, sterile, functionally closed system with a sterile end-to-end isolation path. The Icellator® system – combining the Icellator® and Cartridge Kit – allows for high efficiency enzyme derived stem cell isolation, and minimizes process and cell product variability.
The Icellator® is compact and powerful. Tissue Genesis’ automated cell isolation systems, Icellator® and Icellator® X, make possible the rapid recovery of tens of millions of a patient’s adult stem cells and endothelial progenitor cells at the “point of care.”
Leading the fast-growing field of regenerative medicine, Tissue Genesis was the first company to conduct an FDA approved clinical trial for cell therapy using adipose-derived stem cells isolated at the point-of-care with an automated system. Our expertise, experience and innovation has put us at the forefront of the regenerative medicine market.
Tissue Genesis continues to lead adult stem cell therapeutics with on-going clinical studies, new systems development and a growing collaborative network throughout the world.
For more information, visit www.tissuegenesis.com